黄芪注射液对晚期非小细胞肺癌化疗后外周血象的影响  

Huangqi Injection on hematological system after chemotherapy

作　　者：周秀梅[1] 鲍艳芬[2] 

机构地区：[1]山东省聊城市第二人民医院放疗科,252600 [2]山东省聊城市第二人民医院内科,252600

出　　处：《国际中医中药杂志》2010年第4期311-311,325,共2页International Journal of Traditional Chinese Medicine

摘　　要：目的探讨黄芪注射液对晚期非小细胞肺癌化疗后外周血象的影响。方法按随机数字表法，将100例晚期非小细胞肺癌患者随机分为两组，对照组40例采用MVP方案（丝裂霉素、长春地辛、顺铂）进行化疗，常规加用恩丹西酮、鲨肝醇、利血生治疗。治疗组60例在对照组治疗基础上应用黄芪注射液，疗程结束后比较两组患者疗效。结果治疗组患者白细胞下降、血小板下降、贫血发生率均明显低于对照组，差异有统计学意义（P〈0．05）。结论黄芪注射液可明显减轻晚期非小细胞肺癌患者化疗后的毒副反应。Objective To study the effects of Huangqi Injection on hematological system in advanced nonsmall-cell lung cancer （NSCLC）patients after chemotherapy. Methods A total of 100 NSCLC patients were randomly recruited into a control group （40 patients） and a treatment group （60 patients）. The control group was treated with MVP project （chemotherapy with mitomycin, vindesine, and platinol） and orally taken with ondansetron, batilol, and leucogen; while the treatment group was treated with Huangqi Injection on the basis of the control group. Therapeutic effect was compared between the two groups after the treatment. Results There was a significant decrease of white blood cell count and platelet count in the treatment group. The occurrence of aneamia in the treatment group was significantly lower than the control group （P〈0.05） . Conclusion Huangqi Injection has a obvious effects in reducing toxic and side effects of chemotherapy in NSCLC patients.

关 键 词：黄芪注射液 晚期非小细胞肺癌 血液系统 

分 类 号：R734[医药卫生—肿瘤]